About this item:

365 Views | 273 Downloads

Author Notes:

To whom correspondence should be addressed: Elizabeth J. Corwin, 1520 Clifton Road NE, Atlanta, GA, Tel: 404-712-9805, ejcorwi@emory.edu.

Financial disclosure: The authors of this manuscript declare that there are no actual or potential conflicts of interest.

Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final citable form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.

Subjects:

Research Funding:

This work was supported by NIH grant 1R01NR011278 to EJC and KP.

Keywords:

  • Science & Technology
  • Life Sciences & Biomedicine
  • Immunology
  • Neurosciences
  • Neurosciences & Neurology
  • Postpartum depression
  • Inflammation
  • Cytokines
  • Cortisol
  • Cytokine-cortisol feedback circuit
  • Psychoneuroimmune
  • CORTICOTROPIN-RELEASING HORMONE
  • PITUITARY-ADRENAL AXIS
  • EDINBURGH POSTNATAL DEPRESSION
  • GLUCOCORTICOID-RESISTANCE
  • PERINATAL DEPRESSION
  • PSYCHOLOGICAL STRESS
  • MATERNAL DEPRESSION
  • IMMUNE ACTIVATION
  • PREGNANCY

Bidirectional psychoneuroimmune interactions in the early postpartum period influence risk of postpartum depression

Tools:

Journal Title:

Brain, Behavior, and Immunity

Volume:

Volume 49

Publisher:

, Pages 86-93

Type of Work:

Article | Post-print: After Peer Review

Abstract:

More than 500,000 U.S. women develop postpartum depression (PPD) annually. Although psychosocial risks are known, the underlying biology remains unclear. Dysregulation of the immune inflammatory response and the hypothalamic-pituitary-adrenal (HPA) axis are associated with depression in other populations. While significant research on the contribution of these systems to the development of PPD has been conducted, results have been inconclusive. This is partly because few studies have focused on whether disruption in the bidirectional and dynamic interaction between the inflammatory response and the HPA axis together influence PPD. In this study, we tested the hypothesis that disruption in the inflammatory-HPA axis bidirectional relationship would increase the risk of PPD. Plasma pro- and anti-inflammatory cytokines were measured in women during the 3rd trimester of pregnancy and on Days 7 and 14, and Months 1, 2, 3, and 6 after childbirth. Saliva was collected 5 times the day preceding blood draws for determination of cortisol area under the curve (AUC) and depressive symptoms were measured using the Edinburgh Postpartum Depression Survey (EPDS). Of the 152 women who completed the EPDS, 18% were depressed according to EDPS criteria within the 6. months postpartum. Cortisol AUC was higher in symptomatic women on Day 14 (p=017). To consider the combined effects of cytokines and cortisol on predicting symptoms of PPD, a multiple logistic regression model was developed that included predictors identified in bivariate analyses to have an effect on depressive symptoms. Results indicated that family history of depression, day 14 cortisol AUC, and the day 14 IL8/IL10 ratio were significant predictors of PPD symptoms. One unit increase each in the IL8/IL10 ratio and cortisol AUC resulted in 1.50 (p=0.06) and 2.16 (p=0.02) fold increases respectively in the development of PPD. Overall, this model correctly classified 84.2% of individuals in their respective groups. Findings suggest that variability in the complex interaction between the inflammatory response and the HPA axis influence the risk of PPD.

Copyright information:

© 2015 Elsevier Inc.

This is an Open Access work distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (http://creativecommons.org/licenses/by-nc-nd/4.0/).

Creative Commons License

Export to EndNote